Mark Wainberg

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Mark Wainberg
Born (1945-04-21) April 21, 1945 (age 69)
Fields AIDS research
Alma mater McGill University
Columbia University
Notable awards OC, OQ

Mark A. Wainberg, OC OQ FRSC (born April 21, 1945) is a Canadian HIV/AIDS researcher and HIV/AIDS activist. He is the Director of the McGill University AIDS Centre at the Montreal Jewish General Hospital and Professor of Medicine and of Microbiology at McGill University. His laboratory primarily studies HIV reverse transcriptase, the molecular basis for drug resistance, and gene therapy.[1] He received a B.Sc. from McGill University in 1966, a Ph.D. from Columbia University in 1972, and did his post-doctoral research at Hadassah Medical School of the Hebrew University.

Accomplishments and honors[edit]

Wainberg and his collaborators were the first to identify the antiviral capabilities of 3TC in 1989 and test the drug in patients. 3TC is also called lamivudine.

From 1998 to 2000, Wainberg was President of the International AIDS Society. He was Co-Chair of the XVI International AIDS Conference and a past president of the Canadian Association for HIV Research. Wainberg is an Editor-in Chief of the Journal of the International AIDS Society and Editor of Retrovirology. He is or has been an editor on publications including the Journal of Human Virology, Journal of Leukocyte Biology, International Antiviral News, AIDS Patient Care and STDs, Brazilian Journal of Infectious Diseases and AIDS Research and Human Retroviruses.

In 2001, he was made an Officer of the Order of Canada, Canada's highest civilian honour, for his "major contributions to the study and treatment of" HIV/AIDS.[2] In 2005, he was made an Officer of the National Order of Quebec, an order of merit bestowed by the government of the Province of Quebec.[3] In 2000, he was made a Fellow of the Royal Society of Canada. In 2008, Wainberg was named a Chevalier de Légion d'honneur, the highest honor given by the country of France.[4] In 2014, he was awarded the John G. Fitzgerald - CACMID Outstanding Microbiologist Award, which recognized him as "an individual who is outstanding in all aspects [and]... place him in a similar category to that of the individual the award is named after, Dr. John G. FitzGerald."[5]

Wainberg is also a Past President of Congregation Tifereth Beth David Jerusalem.[6]

AIDS advocacy[edit]

Dr. Wainberg advocates giving AIDS-related relief to developing countries. He has been critical of politicians who ignore the problem of AIDS, including former South African President Thabo Mbeki.[7] Dr. Wainberg also opposes the pseudoscientific ideas of AIDS denialism that are responsible for an estimated 330,000 AIDS deaths in South Africa alone.[8]

In 2006, Dr. Wainberg criticized the Prime Minister of Canada Stephen Harper for his absence from the XVI International AIDS Conference of which Dr. Wainberg was the Co-Chair.[9] In 2004, he was videotaped by AIDS denialist Robin Scovill, whose HIV-positive wife died in 2008 and whose daughter died of untested and untreated AIDS in 2005.[10] In this interview, Dr. Wainberg proposes that those who harm others by publicly questioning HIV as the cause of AIDS should be jailed on charges of public endangerment.

References[edit]

  1. ^ "Mark Wainberg". McGill University. 7 April 2011. Retrieved 9 July 2014. 
  2. ^ Order of Canada citation
  3. ^ "National Order of Quebec citation". 
  4. ^ "Canadian HIV expert named to France's highest order". CBC News. August 21, 2008. 
  5. ^ "Final Program". Association of Medical Microbiology and Infectious Disease Canada. p. 12. Retrieved 9 July 2014. 
  6. ^ "Congregation Tifereth Beth David Jerusalem leadership". TBDJ website. November 27, 2012. 
  7. ^ New York Times July 11, 2000
  8. ^ Researchers Estimate Lives Lost Due to Delay in Antiretroviral Drug Use for HIV/AIDS in South Africa
  9. ^ "AIDS conference opens in Toronto without Harper". CTV.  August 14, 2006
  10. ^ A Mother's Denial, a Daughter's Death: Article from L.A. Times, September 24, 2005